Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

PX TALK: Vivion E750m 2-part, E500m 4.5NC1.5 sr sec 6.00%a, E250m perpNC5.5 sub hybrid 8.25-8.50%

HYC European Market: Deal Flow - General

Vivion Investments Sarl (VIVION) EUR750m Reg S two-part. 

   - EUR500m sr sec notes due 2029 (4.5y). NC1.5 (MWC) (50%,25%,par). Equity claw: 1.5y 40%. Clean up call (80%). NR/BB+ (--/negative). Via Citi (B&D)/GS jt active books/BofA jt books. Off the EMTN programme. List Dublin. English law. CoC at 101. Denoms: 100kX1k. IPT: 6.00%-6.25%. Price talk: 6.00% area (+/-0.125%).

   - EUR250m sub hybrid notes perpetual. NC5.5 (June 2026). NR/B (--/negative). Denoms: 100k. Via Citi (B&D) gloco and structuring advisor/GS jt active books. List Dublin. English law. Interest: fixed rate per annum until  the first reset date. Resets on the first reset date and every 5 years thereafter at the then prevailing 5 year midswap rate + the initial credit spread + applicable step-up. Payable annually. 1st step-up: 25bp; 2nd step-up: 75bp (+100bp cumulative) from the 2nd step-up date June 2046 (year 20.5), provided however that if the issuer rating assigned to the Issuer by S&P is equal to or higher than BBB- on any date, then the 2nd step -up date shall be deemed to be immediately, and irrevocably, changed to June 2051 (year 25.5). Denoms: 100kx100k. Accounting treatment: 100% IFRS equity. IPT: 8.50% area. Price talk: 8.25%-8.50%.

Roadshow (1x1 calls) 11/19-20 (investor call at 11am UKT 11/19).  Books close at 4pm UKT 11/20. Pricing 11/20 UK afternoon. UOP: partially refinance its EUR912m 8.25% sr sec notes due 08/31/28 (callable at 100). Biz: Commercial real estate company, focusing on the ownership, management and improvement of properties in Germany and the United Kingdom. HQ: Luxembourg.

DealRoadshow direck link: https://dealroadshow.com/e/REGULUS2025. Access code: REGULUS2025.


We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.